VacciVets Ltd 15556290 false 2024-10-01 2025-09-30 2025-09-30 The principal activity of the company is Veterinary activities Digita Accounts Production Advanced 6.30.9574.0 true true 15556290 2024-10-01 2025-09-30 15556290 2025-09-30 15556290 core:RetainedEarningsAccumulatedLosses 2025-09-30 15556290 core:ShareCapital 2025-09-30 15556290 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 15556290 core:Non-currentFinancialInstruments core:AfterOneYear 2025-09-30 15556290 bus:SmallEntities 2024-10-01 2025-09-30 15556290 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 15556290 bus:FullAccounts 2024-10-01 2025-09-30 15556290 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15556290 bus:RegisteredOffice 2024-10-01 2025-09-30 15556290 bus:Director1 2024-10-01 2025-09-30 15556290 bus:Director2 2024-10-01 2025-09-30 15556290 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15556290 core:OfficeEquipment 2024-10-01 2025-09-30 15556290 core:PlantMachinery 2024-10-01 2025-09-30 15556290 countries:EnglandWales 2024-10-01 2025-09-30 15556290 2024-03-12 2024-09-30 15556290 2024-09-30 15556290 core:RetainedEarningsAccumulatedLosses 2024-09-30 15556290 core:ShareCapital 2024-09-30 15556290 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 15556290 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 iso4217:GBP xbrli:pure

Registration number: 15556290

VacciVets Ltd
Annual Report and Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 September 2025

VacciVets Ltd

Contents

Abridged Balance Sheet | 1 to 2
Notes to the Unaudited Abridged Financial Statements | 3 to 4

VacciVets Ltd

(Registration number: 15556290)
Abridged Balance Sheet as at 30 September 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 494 | -
Current assets |  |  |
Stocks | 5 | 1,127 | -
Debtors |  | - | 2
Cash at bank and in hand |  | 18,558 | -
|  | 19,685 | 2
Creditors: Amounts falling due within one year |  | (4,658) | -
Net current assets |  | 15,027 | 2
Total assets less current liabilities |  | 15,521 | 2
Creditors: Amounts falling due after more than one year | 6 | (20,000) | -
Net (liabilities)/assets |  | (4,479) | 2
Capital and reserves |  |  |
Called up share capital |  | 2 | 2
Profit and loss account |  | (4,481) | -
Total equity |  | (4,479) | 2

VacciVets Ltd

(Registration number: 15556290)
Abridged Balance Sheet as at 30 September 2025

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

| The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
| The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 11 December 2025 and signed on its behalf by:

Mrs J L Lato

Director

Mr M R Lato

Director

VacciVets Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
11 Sewel Court
Crook
Co. Durham
DL15 9GN

2 | Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis. The director has considered the financial position of the company and considers it to remain viable as a going concern for a period of at least 12 months.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office Equipment | 25% Straight Line
Plant and Machinery | 25% Straight Line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

VacciVets Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

4 | Tangible assets

| Total £
Cost or valuation
Additions | 659
At 30 September 2025 | 659
Depreciation
Charge for the year | 165
At 30 September 2025 | 165
Carrying amount
At 30 September 2025 | 494

5 | Stocks

| 2025 £ | 2024 £
Stock | 1,127 | -

6 | Creditors: amounts falling due after more than one year

Other borrowings

The carrying amount of the loan at year end is £20,000 (2024 - £Nil).